Corrigendum to "Safety of pemetrexed plus platinum in combination with pembrolizumab for metastatic nonsquamous non-small cell lung cancer: A post hoc analysis of KEYNOTE-189" [Lung Cancer 155 (2021) 53-60]
1 David Geffen School of Medicine, University of California Los Angeles, 2825 Santa Monica Blvd, Santa Monica, CA 90404, USA. Electronic address: egaron@mednet.ucla.edu.
2 Erasmus University Medical Center, PO Box 2040, 3000 CA Rotterdam, Netherlands. Electronic address: j.aerts@erasmusmc.nl.
3 Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA. Electronic address: kim_jong_seok@lilly.com.
4 Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA. Electronic address: muehlenbein_catherine_e@lilly.com.
5 Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA. Electronic address: Peterson_patrick@lilly.com.
6 Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA. Electronic address: rizzo_maria_teresa@lilly.com.
7 Henry Ford Cancer Institute/Henry Ford Health System, 2799 W Grand Blvd K13, Detroit, MI 48202, USA. Electronic address: sgadgee1@hfhs.org.